Cyberonics To Begin Non-Epilepsy Studies Of NeuroCybernetic Prosthesis
This article was originally published in The Gray Sheet
Executive Summary
Two human pilot trials for non-epilepsy indications using Cyberonics' NeuroCybernetic Prosthesis system will begin in the next 90 days, company President and CEO Robert Cummins reported at a June 9 session of the annual Piper Jaffray investor conference in Minneapolis.